Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector

X-linked agammaglobulinemia (XLA) is an immune disorder caused by mutations in Bruton’s tyrosine kinase (BTK). BTK is expressed in B and myeloid cells, and its deficiency results in a lack of mature B cells and protective antibodies. We previously reported a lentivirus (LV) BTK replacement therapy t...

Descripción completa

Detalles Bibliográficos
Autores principales: Seymour, Brenda J., Singh, Swati, Certo, Hannah M., Sommer, Karen, Sather, Blythe D., Khim, Socheath, Clough, Courtnee, Hale, Malika, Pangallo, Joseph, Ryu, Byoung Y., Khan, Iram F., Adair, Jennifer E., Rawlings, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907679/
https://www.ncbi.nlm.nih.gov/pubmed/33718514
http://dx.doi.org/10.1016/j.omtm.2021.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907679/
https://www.ncbi.nlm.nih.gov/pubmed/33718514
http://dx.doi.org/10.1016/j.omtm.2021.01.007

Ejemplares similares